Baxter recalls Cefazolin in Dextrose 2g/100mL frozen infusion bags over particles found in the product
The recalled frozen premixed cefazolin infusion bags may contain particulate matter, which means small foreign particles could be present in the medicine.
What to do
The notice does not give instructions. Read the official notice for details.
Recall details
- Product
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
- Hazard
- Presence of Particulate Matter
- Units
- 19,032 bags
- Where sold
- US Nationwide.
- FDA classification
- Class I · Ongoing
- Classified by FDA
- August 21, 2026
- Recall started
- July 24, 2026
- FDA enforcement report
- August 19, 2026
- Identifiers
- Codes: Lot # LD175708, Exp Date: 14-Feb-2027.
- FDA recall number: D-0787-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
- Reason for recall
- Presence of Particulate Matter
- Classification
- Class I (Ongoing)
- Distribution
- US Nationwide.
- Quantity
- 19,032 bags
Related recalls
Baxter recalls 70% Dextrose Injection 2000 mL bags over stainless steel particles in the solution
Stainless steel particles were found in the solution in these intravenous bags, and the notice names this as the reason for the recall of 606 bags sold across the U.S.
Baxter Healthcare Corporation · 606 bags
Baxter recalls 0.9% Sodium Chloride Injection 500 mL bags over fiberglass particles
Some 500 mL bags of 0.9% Sodium Chloride Injection USP in VIAFLEX plastic containers were found to contain particles identified as fiberglass.
Baxter Healthcare Corporation · 145,464 500mL bags
Baxter recalls clindamycin, vasopressin, daptomycin and Cardene IV injections over manufacturing rule violations
The notice says these four Baxter premixed injection products were made with deviations from current good manufacturing practice, and it does not describe a specific defect or health risk.